AC
QDEL icon

Apogem Capital’s QuidelOrtho QDEL Stock Holding History

Apogem Capital’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,492
Closed -$321K – 99
2022
Q3 		$321K Buy
4,492
+988
+28% +$88.4K 0.32% 95
2022
Q2 		$341K Buy
3,504
+1,585
+83% +$162K 0.31% 100
2022
Q1 		$216K Buy
+1,919
New +$205K 0.15% 149

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Apogem Capital's QDEL Position: Q4 2022 in Review

Apogem Capital sold out of QuidelOrtho (QDEL) in Q4 2022, closing a stake of 4,492 shares — an estimated $321K sold.

Apogem Capital first reported a position in QDEL in Q1 2022 and held it in 3 quarters. The position peaked at $341K in Q2 2022. 346 funds tracked by Wall St. Rank hold QDEL as of Q4 2022.

  • Apogem Capital reported no remaining QuidelOrtho position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 4,492 QuidelOrtho shares in Q4 2022, an estimated $321K.
  • Apogem Capital first reported a position in QuidelOrtho in Q1 2022 and held it in 3 quarters.
  • Apogem Capital's QuidelOrtho position peaked at $341K in Q2 2022.
  • 346 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.